Author

María Jiménez-Sánchez

King's College LondonORCID 0000-0002-2287-1582Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Beatriz Gomez Perez‐NievasiD· 2 shared Wendy J. NobleiD· 2 shared Alena Gorb· 1 shared Angela BachiiD· 1 shared Claire TroakesiD· 1 shared Francesca Tarsitano· 1 shared Irina Vázquez-VillaseñoriD· 1 shared Laura FerraiuoloiD· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Beatriz Gomez Perez‐NievasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Proteomics of the astrocyte secretome reveals changes in their response to soluble oligomeric Abeta

Vittoria Matafora, Alena Gorb, Wendy J. Noble, Angela Bachi, Beatriz Gomez Perez‐Nievas, María Jiménez-Sánchez

This study uses proteomics to analyze astrocyte secretome changes in response to soluble Aβ oligomers, identifying dysregulated proteins and potential biomarkers for Alzheimer's disease.

bioRxiv · Jan 18, 2023 · PreprintNeuroscience

Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced tau mislocalization and synaptotoxicity

Beatriz Gomez Perez‐Nievas, Louisa Johnson, Paula Beltran-Lobo, Martina M. Hughes, Luciana Gammallieri, Francesca Tarsitano, Monika A. Myszczynska, Irina Vázquez-Villaseñor, María Jiménez-Sánchez, Claire Troakes, Stephen B. Wharton, Laura Ferraiuolo, Wendy J. Noble

This study shows that astrocytic CXCL1 contributes to Aβ-induced tau mislocalization and synaptotoxicity via CXCR2, suggesting it as a therapeutic target in Alzheimer's disease.

Journal of Neuroinflammation · Dec 1, 2021Peer-reviewedNeuroscience